BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16882664)

  • 21. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
    Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
    Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
    J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells.
    Nishimoto A; Takemoto Y; Saito T; Kurazumi H; Tanaka T; Harada E; Shirasawa B; Hamano K
    Biochem Biophys Res Commun; 2020 Dec; 533(3):548-552. PubMed ID: 32977947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nucleolar helicase DDX56 redistributes to West Nile virus assembly sites.
    Reid CR; Hobman TC
    Virology; 2017 Jan; 500():169-177. PubMed ID: 27821284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.
    Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W
    J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A.
    Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC
    Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
    Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
    Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival.
    Yun HM; Baik JH; Kang I; Jin C; Rhim H
    J Biol Chem; 2010 Mar; 285(13):10016-10029. PubMed ID: 20093369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation.
    Li S; Liu X; Ascoli M
    J Biol Chem; 2000 May; 275(18):13386-93. PubMed ID: 10788448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
    Calligé M; Kieffer I; Richard-Foy H
    Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.
    Bianchi E; Denti S; Granata A; Bossi G; Geginat J; Villa A; Rogge L; Pardi R
    Nature; 2000 Apr; 404(6778):617-21. PubMed ID: 10766246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the mouse JAB1 cDNA and protein.
    Bounpheng MA; Melnikova IN; Dodds SG; Chen H; Copeland NG; Gilbert DJ; Jenkins NA; Christy BA
    Gene; 2000 Jan; 242(1-2):41-50. PubMed ID: 10721695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus.
    Xu Z; Anderson R; Hobman TC
    J Virol; 2011 Jun; 85(11):5571-80. PubMed ID: 21411523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.